{"id":638827,"date":"2026-10-23T06:56:20","date_gmt":"2026-10-23T06:56:20","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/638827\/"},"modified":"2026-10-23T06:56:20","modified_gmt":"2026-10-23T06:56:20","slug":"glp-1-compounded-drugs-facing-nationwide-fda-recall","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/638827\/","title":{"rendered":"GLP-1 compounded drugs facing nationwide FDA recall"},"content":{"rendered":"<p class=\"paragraph | gutter_20_0\">Mounjaro and Zepbound, FDA-approved brand-name versions of tirzepatide shots, aren\u2019t affected by the recall. <\/p>\n<p class=\"paragraph | gutter_20_0\">The <a href=\"https:\/\/www.fda.gov\/drugs\/guidance-compliance-regulatory-information\/human-drug-compounding\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/drugs\/guidance-compliance-regulatory-information\/human-drug-compounding\">FDA defines<\/a> compounding as when a licensed pharmacist, or registered outsourcing facility, mixes or alters drug ingredients, often to create boutique prescription medications for patients who may not be served by brand-name options. <\/p>\n<p class=\"paragraph | gutter_20_0\">Compounded medications are not the same as FDA-approved generic drugs, the agency <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s\">has said<\/a>. <\/p>\n<p class=\"paragraph | gutter_20_0\">Apothecary Pharma LLC was among <a href=\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/registered-outsourcing-facilities\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/registered-outsourcing-facilities\">thousands of pharmacies<\/a> and facilities allowed to produce less expensive, non-FDA-approved versions of GLP-1 drugs during a nationwide shortage of the medications when demand surged in 2022, <a href=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize\">according to the FDA<\/a>. <\/p>\n<p class=\"paragraph | gutter_20_0\">Production of GLP-1 alternatives using semaglutide, an ingredient in Ozempic and Wegovy, was also permitted during the shortage. That shortfall ended in 2025 and compounded production was supposed to cease, <a href=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize\">according to the FDA<\/a>, though many producers have continued making compounded GLP-1s with additional ingredients as a way to skirt the ban, according to <a href=\"https:\/\/jamanetwork.com\/journals\/jama-health-forum\/fullarticle\/2851339\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/jamanetwork.com\/journals\/jama-health-forum\/fullarticle\/2851339\">a study<\/a> in the Journal of the American Medical Association. <\/p>\n<p class=\"paragraph | gutter_20_0\">The popularity of boutique GLP-1 alternatives has outlived the shortage, driven in large part by their significant savings for patients. <\/p>\n<p class=\"paragraph | gutter_20_0\">In 2024, <a href=\"https:\/\/kffhealthnews.org\/health-industry\/health-brief-anti-obesity-drugs-copycats-ozempic-wegovy-mounjaro\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/kffhealthnews.org\/health-industry\/health-brief-anti-obesity-drugs-copycats-ozempic-wegovy-mounjaro\/\">roughly 1 in 3 GLP-1 patients were using these kinds of alternatives<\/a>, according to KFF Health News. Now the figure is <a href=\"https:\/\/news.gallup.com\/poll\/712157\/glp-usage-reaches-new-high.aspx\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/news.gallup.com\/poll\/712157\/glp-usage-reaches-new-high.aspx\">around 1 in 5<\/a> according to a July Gallup report, as GLP-1 usage has continued to soar nationwide. <\/p>\n<p class=\"paragraph | gutter_20_0\">The FDA officially <a href=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.fda.gov\/drugs\/drug-alerts-and-statements\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\">warned patients not to use compounded GLP-1s <\/a> this month unless an individual\u2019s medical needs cannot be met by the name-brand drugs. The agency cited reports of improper storage during shipping and dosing errors that have led to adverse reactions, sometimes requiring hospitalization. Some products, the FDA said, were being made with unapproved ingredients. <\/p>\n<p class=\"paragraph | gutter_20_0\">On Oct. 8, the FDA formally <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/index.cfm?Event=99952\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/index.cfm?Event=99952\">classified the Apothecary Pharma LLC recall<\/a> as presenting only a \u201cremote\u201d possibility of serious adverse health consequences. In March, the agency <a href=\"https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/apothecary-pharma-llc-717972-12012025\" target=\"_blank\" rel=\"nofollow noopener\">warned the company<\/a> that investigators \u201cnoted serious deficiencies\u201d in sterility protocols, placing \u201cpatients at risk.\u201d<\/p>\n<p class=\"paragraph | gutter_20_0\">In the notice, the FDA did not say whether the recalled injections were contaminated, or what patients should do with their vials. <\/p>\n<p class=\"paragraph | gutter_20_0\">Officials from the FDA and Apothecary Pharma LLC did not respond to a request for comment Wednesday. <\/p>\n<p class=\"paragraph | gutter_20_0\">This year, <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s\" target=\"_blank\" rel=\"nofollow noopener\">the FDA has also issued warning letters<\/a> against many small pharmacies for promoting their compounded products as being the same as the brand-name labels. <\/p>\n<p class=\"paragraph | gutter_20_0\">Drug makers like Eli Lilly <a href=\"https:\/\/www.npr.org\/sections\/shots-health-news\/2025\/04\/23\/nx-s1-5374063\/eli-lilly-sues-companies-selling-alternative-versions-of-its-weight-loss-drug\" target=\"_blank\" rel=\"nofollow noopener\">have sued<\/a> to block continued production of GLP-1 alternatives, NPR reported. <\/p>\n<p class=\"paragraph | gutter_20_0\">The FDA said the following compound lots, which were available by prescription only and sold in 18mg\/mL and 4 mL sterile multi-dose vials, are subject to the ongoing nationwide recall:<\/p>\n<p>Lot AP-202622, BUD 07-Oct-2026Lot AP-202623, BUD 08-Oct-2026Lot AP-202624, BUD 19-Oct-2026Lot AP-202625, BUD 10\/20\/2026Lot AP-202627, BUD 10\/26\/2026 Lot AP-202628, BUD 10\/27\/2026Lot AP-202629, BUD 10\/28\/2026Lot AP-202630, BUD 10\/31\/2026Lot AP-202631, BUD 11\/01\/2026Lot AP-202632, BUD 11\/03\/2026Lot AP-202633, BUD 11\/07\/2026Lot AP-202634, BUD 11\/08\/2026Lot AP-202635, BUD 11\/16\/2026Lot AP-202636, BUD 11\/17\/2026Lot AP-202637, BUD 11\/18\/2026Lot AP-202638, BUD 11\/19\/2026Lot AP-202639, BUD 11\/20\/2026Lot AP-202640, BUD 11\/21\/2026Lot AP-202641, BUD 11\/22\/2026Lot AP-202642, BUD 11\/24\/2026Lot AP-202643, BUD 11\/25\/2026Lot AP-202644, BUD 11\/26\/2026<\/p>\n<p class=\"tagline | font_primary inline_block  margin_top_32\">Bryan Hecht can be reached at <a href=\"https:\/\/www.bostonglobe.com\/2026\/10\/21\/business\/glp-1-alternative-drugs-face-nationwide-recall\/mailto:bryan.hecht@globe.com\" class=\"\" target=\"_blank\" style=\"font-size:inherit;letter-spacing:.5px\" rel=\"nofollow noopener\">bryan.hecht@globe.com<\/a>. Follow him on Instagram <a href=\"https:\/\/www.instagram.com\/bhechtjournalism\" class=\"\" target=\"_blank\" style=\"font-size:inherit;letter-spacing:.5px\" rel=\"nofollow noopener\">@bhechtjournalism<\/a>.<\/p>\n<p><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"Mounjaro and Zepbound, FDA-approved brand-name versions of tirzepatide shots, aren\u2019t affected by the recall. The FDA defines compounding&hellip;\n","protected":false},"author":2,"featured_media":638828,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[14850,46227,1221,134,581,57870,13634,112568,524,111,139,69,4368,5296,550,37623,14851,313096],"class_list":["post-638827","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-bestof","tag-essential","tag-france","tag-health","tag-horizontal","tag-illustration","tag-ingredient","tag-inside-of","tag-medication","tag-new-zealand","tag-newzealand","tag-nz","tag-obesity","tag-photography","tag-social-issues","tag-tirzepatide","tag-topix","tag-valenciennes"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/638827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=638827"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/638827\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/638828"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=638827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=638827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=638827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}